Specifically, we observed an upregulation of antiviral genes, including rig-i, mx1, ifn-γ, irf3, and mda5, which are known to be crucial for effective antiviral responses in mucosal surfaces, particularly during the early stages of infection [40, 41]. This evidence concerns the gene IRF3 and infection.